Medication Access Outreach Market Size, Share & Forecast 2026-2033

The global medication access outreach market is set for sustained expansion through 2033, with the market projected to grow at a CAGR of 8.6% from 2026 to 2033 and reach about $18.4 billion by the end of the forecast period. This market covers programs and service platforms that help patients obtain prescribed medicines through affordability support, refill coordination, adherence outreach, specialty pharmacy navigation, benefit verification, and patient education. Demand is being shaped by higher chronic disease loads, rising prescription complexity, tighter payer management, and the growing need for healthcare organizations to reduce abandonment at the pharmacy counter. It sits at the intersection of care coordination, pharmacy services, digital engagement, and patient assistance, which makes it increasingly important for health systems, payers, and manufacturers.

From 2019 to 2025, the market moved from a fragmented service layer into a more structured operating category as providers and pharmaceutical companies responded to growing access friction, especially in specialty medicines and branded therapies. The market is estimated to have expanded from roughly $6.2 billion in 2019 to about $10.7 billion in 2025, supported by broader use of support hubs, prior authorization help, copay support, and automated outreach. In 2026, the base year, the market is estimated at around $11.6 billion, and the forecast to 2033 implies steady annual gains as outreach becomes more embedded in patient journey management and pharmacy operations. The growth path is not just volume-driven; it is also driven by higher service intensity per patient, particularly in oncology, immunology, diabetes, cardiovascular care, and rare disease programs.

The United States remains the largest market by a wide margin, with 2026 spending estimated near $4.2 billion and a forecast pace slightly above the global average because of complex insurance navigation, high out-of-pocket pressure, and the heavy use of specialty drugs. Demand is concentrated in health systems, specialty pharmacies, and manufacturer-sponsored patient services, with investment directed toward digital enrollment, closed-loop adherence workflows, and predictive outreach to reduce abandonment. China is the second most important growth market, estimated at about $1.1 billion in 2026, supported by expanding urban insurance coverage, hospital pharmacy modernization, and a growing middle class that is more willing to pay for branded therapy access support. In Germany, where the market is valued near $540 million, growth is shaped by structured statutory coverage, a strong hospital and outpatient pharmacy base, and rising attention to medication persistence for aging patients.

Japan’s market, estimated at roughly $610 million in 2026, is supported by a large elderly population, high chronic disease prevalence, and strong prescription adherence programs tied to community pharmacies and hospital networks. India, at about $480 million, is growing faster than most peers because affordability remains a primary barrier, and outreach services are increasingly tied to generic access, digital prescription fulfillment, and private hospital expansion. South Korea, estimated near $290 million, benefits from advanced digital health adoption and efficient payer systems, while Italy and France, at approximately $260 million and $330 million respectively, rely more heavily on public coverage coordination and hospital-linked patient support. The United Kingdom, close to $370 million, is influenced by NHS pathways, medicine adherence initiatives, and pharmacy-led patient contact models, while Canada, at about $240 million, shows steady demand tied to private insurance complexity and provincial program navigation.

Mexico and Brazil together represent major Latin American opportunities, with 2026 market sizes of roughly $210 million and $390 million, respectively, as access outreach gains importance in private insurance, retail pharmacy, and chronic care programs. Turkey, at about $170 million, is shaped by inflation pressure, reimbursement constraints, and rising demand for lower-cost medicine access services, while Indonesia and Vietnam, estimated at $150 million and $120 million, are still early in adoption but are seeing rising demand in urban centers and private provider networks. Saudi Arabia and the United Arab Emirates, valued near $140 million and $110 million, are developing access programs around premium care, digital health infrastructure, and imported specialty medicines. South Africa, Australia, Thailand, Spain, the Netherlands, Poland, Malaysia, and Argentina together form a mixed cluster where public coverage systems, private pharmacy networks, and affordability gaps drive different levels of demand, with Australia near $190 million, Spain around $250 million, the Netherlands about $160 million, and Poland, Malaysia, and Argentina ranging between $95 million and $140 million. Stats N Data estimates these markets are moving toward more integrated patient support models, especially where reimbursement complexity and chronic disease burden overlap.

Market segmentation by type shows that affordability assistance, adherence outreach, enrollment and benefit verification, and refill coordination are the most commercially important service lines. Affordability and copay support account for the largest share in 2026 at around 31% of global revenue, followed by adherence and refill engagement at 27%, while benefit verification and prior authorization support hold about 22%, and education and navigation services make up the rest. By application, specialty drugs lead because they require the most touchpoints, but chronic disease management is the broadest volume segment due to long treatment durations and recurring refill behavior. Regionally, North America holds the largest share at about 41%, Europe follows at 27%, Asia-Pacific is close behind at 23%, and Latin America, the Middle East, and Africa together account for the remaining share, with growth skewing faster in emerging markets than in mature ones.

Several forces are supporting demand, but the most important is the widening gap between prescription availability and prescription affordability. As patients face deductibles, formulary restrictions, and more complex prior authorization rules, healthcare organizations are using outreach programs to prevent drop-off at the first fill and to keep patients on therapy longer. The shift toward specialty and chronic medicines also increases the value of personalized contact, because one missed refill can quickly erode outcomes and revenue. Digital channel adoption is accelerating this process, since mobile reminders, text-based support, and workflow automation lower service costs while increasing engagement rates.

A key restraint is that the economics remain uneven, especially in markets where reimbursement for access support is unclear or where manufacturers are expected to fund most of the service burden. Regulatory sensitivity around patient data, promotional boundaries, and consent handling also limits how aggressively organizations can scale outreach. In lower-income countries, limited digital reach, weak address systems, and fragmented pharmacy infrastructure reduce the efficiency of every dollar spent on outreach. Even in advanced markets, the return on investment is not always immediate, because programs often reduce leakage in ways that are hard to measure in quarterly financial terms.

The strongest opportunity lies in integrated platforms that connect prescribing, prior authorization, fulfillment, counseling, and adherence tracking into one workflow. That creates value for providers who want better outcomes, for payers who want fewer avoidable escalations, and for manufacturers who need higher therapy persistence. There is also room for expansion in emerging markets where private insurance penetration is rising faster than service infrastructure, especially in urban India, Southeast Asia, and parts of Latin America. In practice, the next wave of growth will favor companies that can combine patient services with measurable clinical and economic results rather than simply offering call-center support.

The market still faces several operational challenges, most notably labor intensity, service inconsistency, and the difficulty of personalizing outreach at scale across different languages, reimbursement rules, and care settings. Many organizations struggle to prove that outreach programs directly reduce total cost of care, which can slow budget approval and limit long-term contracts. Competition is also increasing as pharmacies, health systems, technology vendors, and payer service providers all try to own more of the patient journey. As a result, programs must be designed with clearer attribution, better integration, and faster response times if they are to protect margins and retain clients.

Technology is reshaping the market through automation, predictive analytics, and AI-assisted patient segmentation. Systems are increasingly able to identify patients at risk of abandonment, missed refills, or benefit disruption before the problem occurs, which improves timing and lowers outreach waste. Digital intake, e-signature, and workflow orchestration are now standard in higher-performing programs, while multilingual chat and voice tools are expanding access in diverse populations. The best operators are moving beyond simple reminders and toward coordinated, data-driven interventions that align pharmacy, provider, and payer activity.

Regional performance reflects different healthcare structures and purchasing behavior. North America leads on revenue because of higher service intensity and stronger willingness to pay for access navigation, while Europe shows steadier but more policy-shaped growth through public systems and pharmacy-led support. Asia-Pacific is the fastest-growing regional block, supported by larger patient volumes, mobile-first engagement, and private healthcare expansion in countries such as India, China, Indonesia, and Vietnam. Latin America, the Middle East, and Africa remain smaller in absolute size, but they offer attractive growth pockets where affordability support and distribution coordination solve immediate access failures.

Competition is fragmented, with no single player controlling the market across all services and geographies. Large pharmacy chains, patient support specialists, digital health vendors, contract service firms, and manufacturer-affiliated hubs all compete for workflow ownership, and many providers now expect bundled offerings rather than single-point solutions. Margin pressure is rising in commoditized services, so vendors are differentiating through analytics, payer integration, multilingual support, and performance-based contracts. In the middle of this shift, Stats N Data observes that buyers are increasingly selecting partners that can show measurable improvements in fill rate, persistence, and patient satisfaction rather than broad service claims.

The analytical approach behind this market view is based on service-line revenue mapping, patient access workflow analysis, regional reimbursement patterns, and cross-checking of adoption trends across provider, pharmacy, and manufacturer channels. Historical estimates from 2019 to 2025 were normalized to account for the pandemic-era disruption, the rebound in elective care, and the acceleration of digital patient services. Forecasting for 2026 to 2033 assumes continued growth in specialty utilization, gradual digitization of outreach operations, and steady expansion in emerging-market access programs. Sensitivity is highest in countries where regulation or reimbursement shifts can quickly change service demand, so the outlook is best read as a base-case trajectory rather than a fixed outcome.

Strategically, the best-positioned firms will build scalable platforms that lower service cost per patient while improving adherence and first-fill conversion. They should prioritize markets with high prescription complexity and visible affordability friction, because those conditions support recurring engagement and stronger contract economics. Partnerships with pharmacies, payers, hospitals, and patient groups will matter more than standalone selling, especially where trust and local workflow integration determine adoption. Companies that invest in automation, localized service models, and outcome reporting will be better placed to capture share as medication access becomes a standard part of modern care delivery.

The Medication Access Outreach market plays a pivotal role in enhancing patient access to essential medications, particularly for underserved populations who may face barriers due to financial, geographical, or informational challenges. This sector involves strategies and initiatives designed to help patients navigate the complexities of prescription drug access, including assistance programs, advocacy efforts, and educational outreach. As healthcare continues to evolve, the importance of Medication Access Outreach has grown significantly, with stakeholders recognizing that improving access to medications not only enhances individual health outcomes but also contributes to broader public health goals.

According to a recently published report by STATS N DATA, the Medication Access Outreach market has seen substantial growth, with the current market size estimated and historical data illustrating a steady increase in demand. This trend is expected to continue, driven by a variety of factors including an aging population, rising healthcare costs, and the increasing prevalence of chronic diseases. Furthermore, as innovative therapies and specialty medications enter the market, the complexity of obtaining these treatments necessitates enhanced access strategies. Growth projections suggest that the market will expand at a robust rate over the coming years, fueled by the ongoing push for health equity and improved patient-centered care.

Key drivers propelling the Medication Access Outreach market include an enhanced focus on social determinants of health and the growing recognition of the need for tailored interventions to address specific community challenges. However, the market does face certain restraints, including regulatory hurdles and variability in funding for outreach programs. Opportunities abound in the realm of technological advancements, with digital platforms and telehealth solutions facilitating more efficient outreach and support for patients. Moreover, the integration of data analytics is enabling organizations to better understand patient needs and optimize their outreach strategies. As the landscape of healthcare continues to be shaped by these dynamic factors, the Medication Access Outreach market stands as a crucial component in ensuring that all patients have timely access to the medications they require for improved health and well-being.

The global business environment is constantly evolving, and keeping up with the latest trends in the MEDICATION ACCESS OUTREACH MARKETis essential for businesses aiming to succeed. Our detailed market research report by STATS N DATA serves as a crucial resource for investors and companies, offering comprehensive insights into the Global Medication Access Outreach Industry. This report goes beyond mere data analysis, providing advanced revenue projections, in-depth forecasts, and a thorough examination of future trends from 2026 to 2033. For decision-makers navigating this dynamic market, our report is an indispensable guide, helping craft strategies aligned with the market's anticipated growth and changes.

Market Overview and Historical Perspective

The report begins with a detailed overview of the Medication Access Outreach Market, focusing on its current size, scope, and structure. By leveraging extensive historical data, the report uncovers key insights that trace the market's evolution over time. Understanding past trends and market patterns gives stakeholders a solid foundation for predicting future developments in the Medication Access Outreach Market. This historical perspective is essential for identifying growth opportunities and innovative paths forward, allowing businesses to position themselves advantageously.

Future Insights and Market Projections

In addition to historical analysis, the report offers forward-looking insights into the future of the Medication Access Outreach Market. Expert forecasts and detailed analyses of emerging trends provide stakeholders with a clear view of the market's expected direction. By identifying key growth drivers, such as technological innovations and increasing demand across various sectors, the report outlines the factors propelling the market forward. It also considers potential challenges like regulatory changes and economic uncertainties, equipping stakeholders with the knowledge needed to adapt and thrive.

Market Segmentation

The Medication Access Outreach Market is segmented into various categories, including product type, application/end-user, and geography. Detailed segmentation is outlined as follows:

Type

• Patient Assistance Programs
• Prescription Assistance Programs
• Accessible Healthcare Initiatives

Application

• Affordable Medication Access
• Medication Support for Low-Income Individuals
• Access to Specialty Medications
• Disease-specific Programs

Each segment is thoroughly examined to understand its role and impact on overall market dynamics. This section evaluates the size and growth rate of each segment, helping stakeholders pinpoint areas with significant expansion potential. This segmentation analysis is crucial for identifying the market's key drivers and understanding which areas offer the most promise for future development.

Additionally, the report includes a market attractiveness analysis, assessing the appeal of each segment based on factors such as market potential, competitive intensity, and growth prospects. This analysis provides a comprehensive view of which segments present the best opportunities for investment and strategic initiatives, enabling stakeholders to allocate resources effectively.

Geographic Analysis

The report also delves into the geographical segmentation of the Medication Access Outreach Market, offering an in-depth analysis of major regions including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Each region is assessed based on market size, growth rate, and key trends, providing stakeholders with valuable insights into regional dynamics and expansion opportunities. This geographical analysis is critical for understanding the global landscape of the Medication Access Outreach Market and tailoring strategies to fit specific regional markets.

Competitive Landscape

Companies profiled in this report are

• NeedyMeds
• Partnership for Prescription Assistance (PPA)
• Rx Outreach
• HealthWell Foundation
• Patient Access Network Foundation (PAN)
• PAN Foundation
• Together Rx Access
• Patient Services Inc.
• RxHope
• Bridge the Gap Foundation

The competitive landscape of the Medication Access Outreach Market is characterized by vigorous competition among leading players, all vying to maintain and expand their market share. Our report offers a comprehensive overview of this competitive environment, profiling major companies and analyzing their market positions. This section includes detailed SWOT analyses for each key competitor, highlighting their strengths, weaknesses, opportunities, and threats. Understanding these dynamics is vital for stakeholders looking to refine their strategies and secure a competitive edge.

The report also explores strategic moves by key players, including mergers, acquisitions, partnerships, and new product developments. Staying updated on these activities helps stakeholders anticipate changes in the competitive landscape and adjust their strategies accordingly.

Furthermore, the report features a benchmarking analysis of key products and services within the Medication Access Outreach Market. This comparison sheds light on the performance and market positioning of various offerings, helping stakeholders identify best practices and areas for improvement. This analysis is crucial for stakeholders aiming to enhance their competitive positioning and sustain a strong market presence.

Recent Developments

Significant developments have recently shaped the Global Medication Access Outreach Market, including mergers, acquisitions, partnerships, and innovative product launches. Our report provides an in-depth analysis of these recent changes, offering stakeholders insights into how these activities have influenced the market's competitive dynamics.

Beyond mergers and acquisitions, the report highlights strategic alliances and partnerships formed between key players in the Medication Access Outreach Market. These collaborations are essential for driving innovation and expanding market reach, and understanding these dynamics can help stakeholders identify potential opportunities for partnership and growth.

Moreover, the report includes a detailed analysis of recent product launches and technological innovations within the Medication Access Outreach Market. This section spotlights the latest advancements and emerging trends, providing stakeholders with crucial information on new opportunities. Staying informed about these developments is key for stakeholders looking to maintain a competitive edge.

Technological Advancements and Future Disruptions

Technological advancements are a major driver of change in the Global Medication Access Outreach Market. Our report highlights the most impactful technological trends, showing how these innovations are reshaping the industry. This section offers a comprehensive overview of the latest technological developments, including breakthroughs in product design, manufacturing techniques, and digital technologies.

The report also examines the impact of these technological advancements on the Medication Access Outreach Market, exploring how they are altering industry dynamics and creating new opportunities for growth. This analysis is essential for stakeholders looking to leverage technology to enhance their competitive positioning and meet evolving market demands.

Additionally, the report provides insights into future technological innovations that have the potential to disrupt the market. These emerging technologies are poised to create new growth opportunities and challenges, and staying informed about these developments is crucial for stakeholders aiming to stay ahead of the competition.

Industry Dynamics and Market Structure

The report offers a detailed examination of the overall structure and dynamics of the Medication Access Outreach Market, helping stakeholders understand the industry's key components and their interactions. Understanding these elements is vital for identifying collaboration and innovation opportunities that drive market growth.

The report also explores the key factors influencing industry dynamics, including economic, regulatory, and technological aspects. By understanding these dynamics, stakeholders can develop strategies that align with the industry's overall structure and capitalize on emerging opportunities.

Moreover, the report provides insights into the evolving nature of the Medication Access Outreach Market?s value chain. This analysis follows the process from suppliers to end-users, highlighting where value is added at each stage. By optimizing the value chain, stakeholders can improve operational efficiency and secure a competitive advantage.

Porter's Five Forces Analysis

Our Medication Access Outreach Market report employs Porter's Five Forces Analysis to offer a strategic framework for understanding the competitive landscape. This analysis evaluates the bargaining power of buyers and suppliers, the threat of new entrants and substitute products, and the intensity of competitive rivalry. These insights are crucial for stakeholders looking to understand the factors that influence the industry's profitability and competitiveness.

The report also explores how these forces might evolve over time, providing stakeholders with insights into future competitive dynamics. By understanding these forces, stakeholders can develop strategies that enhance their market position and mitigate potential risks.

Value Chain Analysis

The Medication Access Outreach Market report includes a comprehensive value chain analysis, offering stakeholders a detailed understanding of the process from suppliers to end-users. This analysis highlights each phase of the value chain, showing where value is added and identifying potential areas for efficiency improvements or strategic adjustments. By optimizing the value chain, stakeholders can enhance their operational efficiency and secure a competitive edge.

In addition to mapping the value chain, the report explores the key drivers of value creation within the Medication Access Outreach Market. Understanding these drivers is critical for stakeholders seeking to maximize their return on investment and drive business growth.

Customer Preferences and Market Trends

Understanding customer preferences and market trends is vital for success in the Medication Access Outreach Market. The report identifies key consumer expectations and trends, providing clarity on what consumers value most in products and services. This section explores how these preferences are evolving, offering stakeholders insights into how they can tailor their offerings to meet changing consumer demands.

The report also examines the impact of these trends on the market, analyzing how shifts in consumer preferences are driving changes in the industry. By aligning their strategies with customer needs, stakeholders can improve customer satisfaction, build brand loyalty, and drive business growth.

Regulatory Landscape

The regulatory environment plays a critical role in shaping the Medication Access Outreach Market. Our report provides a comprehensive overview of the key regulations and standards that impact the industry. This section examines the legal and regulatory framework governing the market, giving stakeholders a clear understanding of the rules and guidelines they must follow.

The report also explores the implications of recent regulatory changes, evaluating how these modifications are shaping the market and affecting stakeholders. Understanding the regulatory landscape is essential for stakeholders looking to stay compliant and avoid potential legal complications.

Additionally, the report provides insights into potential future regulatory developments. Staying informed about these changes is crucial for stakeholders seeking to anticipate challenges and adjust their strategies accordingly.

Market Entry Strategies

Entering the Medication Access Outreach Market presents several challenges, including high barriers to entry and intense competition. This report identifies the main obstacles new entrants must overcome to successfully penetrate the market, such as significant capital requirements, stringent regulatory standards, and the presence of established competitors.

The report also outlines critical success factors for new entrants in the Medication Access Outreach Market, covering essential aspects like innovation, effective marketing strategies, strategic partnerships, and a strong value proposition. By focusing on these key elements, new entrants can effectively manage market complexities and improve their chances of success.

Additionally, the report offers strategic recommendations for market entry, providing practical advice on market positioning, customer acquisition strategies, and differentiation tactics. These strategies are tailored to help new entrants establish a strong market presence and gain a competitive edge in the Medication Access Outreach Market.

Economic Indicators and Risk Analysis

The report explores the impact of macroeconomic factors on the Medication Access Outreach Market, including GDP growth, inflation rates, and employment trends. This analysis offers stakeholders a comprehensive understanding of the broader economic environment and its influence on the market, supporting informed decision-making.

The report also examines the risks and uncertainties within the Medication Access Outreach Market, highlighting potential challenges to market stability and growth. These risks include economic volatility, regulatory shifts, and intense market competition. By understanding these risks, stakeholders can develop strategies to mitigate them and strengthen market resilience.

Additionally, the report provides specific strategies for mitigating identified risks. The section on impact assessment and mitigation offers actionable recommendations that help Medication Access Outreach Market participants manage risks effectively and maintain stability. By proactively addressing these risks, stakeholders can protect their interests and support sustainable growth.

Investment Analysis and Opportunities

This research evaluates key suppliers and distributors in the Medication Access Outreach Market, highlighting the primary entities involved in providing and distributing products. The report offers insights into their capabilities, reliability, and strategic significance within the supply chain. Understanding these dynamics allows stakeholders to optimize their operations and strengthen their market positions.

The report also identifies prime investment opportunities and offers strategic recommendations. It highlights areas with substantial potential for high returns, helping investors make informed decisions about resource allocation for maximum impact. Strategic investments in these high-potential areas can significantly increase profitability and stimulate market growth.

The report includes a comprehensive analysis of return on investment (ROI) and financial projections. This analysis is crucial for assessing the expected profitability of investments and developing informed financial strategies. Understanding these financial forecasts is essential for evaluating potential returns and associated risks of various investment avenues. By leveraging data-driven investment decisions, stakeholders can maximize their returns and achieve their financial objectives.

Moreover, the report includes feasibility studies for potential new projects or ventures. These studies evaluate the viability of new endeavors by analyzing market demand, cost estimates, and potential revenue. Such evaluations ensure that investors can make well-informed decisions about pursuing new opportunities. Engaging in feasible projects allows stakeholders to expand their market presence and drive business growth.

Technological and Innovation Insights

The Medication Access Outreach Market report explores emerging technologies and their potential impact on the market, highlighting how these advancements are setting the stage for the industry's future. This section focuses on innovations that could disrupt the market landscape, creating new opportunities for growth and innovation.

Additionally, the report provides a detailed analysis of the innovation landscape and research and development (R&D) activities within the Medication Access Outreach Market. It examines ongoing R&D efforts and the overall state of innovation, offering a comprehensive view of how companies are driving progress and maintaining competitiveness. This analysis is critical for understanding the role of innovation in market growth and identifying areas for strategic investment.

Furthermore, the report explores the potential of disruptive technologies within the Medication Access Outreach Market. These technologies have the capacity to reshape the industry, creating new opportunities and challenges. By staying informed about these emerging technologies, stakeholders can proactively adjust their strategies and leverage innovation to secure a competitive advantage.

Geographical Insights

The report delivers a thorough geographical analysis of the Medication Access Outreach Market, offering insights into regional trends and opportunities. This section covers key regions, including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Understanding these regional dynamics is essential for identifying growth opportunities and tailoring strategies to specific markets.

Regional Highlights

The analysis also highlights regional trends and developments, emphasizing the most significant market drivers and challenges in each area. By understanding these regional dynamics, stakeholders can make informed decisions about market entry, expansion, and resource allocation.

Market Size and Regional Growth

The report examines the market size and growth rate across different regions, providing a clear view of which areas are experiencing the most rapid growth. This information is crucial for identifying key markets and planning strategic initiatives.

Emerging Markets and Strategic Opportunities

The report identifies emerging markets with high growth potential, offering strategic recommendations for capitalizing on these opportunities. Understanding these emerging markets is vital for stakeholders looking to expand their presence and tap into new growth areas.

FAQ

• What is the Global Medication Access Outreach Market size, and what growth rate can be expected during the forecast period?

• What are the key factors driving the growth of the Medication Access Outreach Market?

• What challenges and risks does the Medication Access Outreach Market currently face?

• Who are the major players in the Medication Access Outreach Market?

• What are the current trends influencing the shares of the Medication Access Outreach Market?

• What insights can be gleaned from applying Porter's Five Forces model to the Medication Access Outreach Market?

• What global expansion opportunities are available in the Medication Access Outreach Market?

Our comprehensive market research report on the Global Medication Access Outreach Market is an invaluable resource for investors, executives, and companies looking to deepen their understanding of the industry. With detailed analyses, actionable insights, and strategic recommendations, this report equips stakeholders with the knowledge they need to make informed decisions and capitalize on the opportunities within the Medication Access Outreach Market. We encourage you to leverage these insights to enhance your strategic planning and secure a competitive edge in this dynamic market.